Search by Drug Name or NDC

    NDC 61919-0250-04 GLIMEPIRIDE 4 mg/1 Details

    GLIMEPIRIDE 4 mg/1

    GLIMEPIRIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by DIRECT RX. The primary component is GLIMEPIRIDE.

    Product Information

    NDC 61919-0250
    Product ID 61919-250_f2030f1c-9993-4b65-e053-2995a90ac5eb
    Associated GPIs 27200027000340
    GCN Sequence Number 025181
    GCN Sequence Number Description glimepiride TABLET 4 MG ORAL
    HIC3 C4K
    HIC3 Description ANTIHYPERGLYCEMIC, INSULIN-RELEASE STIMULANT TYPE
    GCN 05833
    HICL Sequence Number 010485
    HICL Sequence Number Description GLIMEPIRIDE
    Brand/Generic Generic
    Proprietary Name GLIMEPIRIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name GLIMEPIRIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 4
    Active Ingredient Units mg/1
    Substance Name GLIMEPIRIDE
    Labeler Name DIRECT RX
    Pharmaceutical Class Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078181
    Listing Certified Through 2024-12-31

    Package

    NDC 61919-0250-04 (61919025004)

    NDC Package Code 61919-250-04
    Billing NDC 61919025004
    Package 4 TABLET in 1 BOTTLE (61919-250-04)
    Marketing Start Date 2016-02-04
    NDC Exclude Flag N
    Pricing Information N/A